Total pancreatectomy combined with partial pancreas autotransplantation for recurrent pancreatic cancer: a case report

Transplant Proc. 2012 May;44(4):1176-9. doi: 10.1016/j.transproceed.2012.03.016.

Abstract

We describe a patient presenting with a resectable carcinoma of the remnant pancreas at 3 years after undergoing a pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreatic head. We also performed a distal pancreas autotransplantation using a part of the resected pancreas to preserve endocrine function. Final histologic findings showed the second tumor to be an invasive ductal carcinoma consisting of a well-differentiated tubular adenocarcinoma with similar histopathologic findings as the first tumor. There were no microscopic lymph node metastases and no evidence of microvascular invasion (pStage IA [pT1, pN0, M0] and R0 according to the International Union Against Cancer TNM classification). The patient was discharged at 20 days after surgery without any trouble and followed by adjuvant chemotherapy with S-1. The carbohydrate antigen 19-9 value was again normalized after the second surgery. Twenty months after the second operation, the patient is alive without cancer recurrence. The pancreas graft is functioning with a blood glucose of 108 mg/dL, HbA1C of 6.2%, and serum C-peptide of 1.4 ng/mL.

Publication types

  • Case Reports

MeSH terms

  • Blood Glucose / metabolism
  • C-Peptide / blood
  • CA-19-9 Antigen / blood
  • Carcinoma, Pancreatic Ductal / diagnostic imaging
  • Carcinoma, Pancreatic Ductal / pathology
  • Carcinoma, Pancreatic Ductal / surgery*
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local*
  • Neoplasm Staging
  • Pancreas Transplantation*
  • Pancreatectomy*
  • Pancreatic Function Tests
  • Pancreatic Neoplasms / diagnostic imaging
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Pancreaticoduodenectomy*
  • Reoperation
  • Time Factors
  • Tomography, X-Ray Computed
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Blood Glucose
  • C-Peptide
  • CA-19-9 Antigen
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human